These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36115894)

  • 1. Microarray profiling identifies hsa_circ_0082003 as a novel tumor promoter for papillary thyroid carcinoma.
    Ye J; Feng JW; Wu WX; Qi GF; Wang F; Hu J; Hong LZ; Liu SY; Jiang Y
    J Endocrinol Invest; 2023 Mar; 46(3):509-522. PubMed ID: 36115894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4.
    Qi Y; He J; Zhang Y; Wang L; Yu Y; Yao B; Tian Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic potential of two exosome-derived circRNAs for papillary thyroid cancer.
    Dai L; Hu W; Jiang H; Wang Y; Le Q; Wu X; Meng X
    Int J Clin Oncol; 2023 Nov; 28(11):1461-1474. PubMed ID: 37568034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA profiling reveals a potential role of hsa_circ_IPCEF1 in papillary thyroid carcinoma.
    Guo M; Sun Y; Ding J; Li Y; Yang S; Zhao Y; Jin X; Li SS
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis.
    Yao Y; Chen X; Yang H; Chen W; Qian Y; Yan Z; Liao T; Yao W; Wu W; Yu T; Chen Y; Zhang Y
    J Exp Clin Cancer Res; 2019 Jul; 38(1):318. PubMed ID: 31324198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa_circ_0039411 promotes tumorigenesis and progression of papillary thyroid cancer by miR-1179/ABCA9 and miR-1205/MTA1 signaling pathways.
    Yang Y; Ding L; Li Y; Xuan C
    J Cell Physiol; 2020 Feb; 235(2):1321-1329. PubMed ID: 31270819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Expression of hsa_circ_0002111 and Its Clinical Significance in Papillary Thyroid Cancer.
    Du G; Ma R; Li H; He J; Feng K; Niu D; Yin D
    Front Oncol; 2021; 11():644011. PubMed ID: 33718243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of hsa_circ_0137287 predicts aggressive clinicopathologic characteristics in papillary thyroid carcinoma.
    Lan X; Cao J; Xu J; Chen C; Zheng C; Wang J; Zhu X; Zhu X; Ge M
    J Clin Lab Anal; 2018 Oct; 32(8):e22573. PubMed ID: 29790216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway.
    Sun Z; Zhang M; Ye Y; Yang L
    Horm Metab Res; 2024 May; 56(5):381-391. PubMed ID: 38286403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circ_0005273 promotes thyroid carcinoma progression by SOX2 expression.
    Zhang W; Zhang H; Zhao X
    Endocr Relat Cancer; 2020 Jan; 27(1):11-21. PubMed ID: 31693489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
    Zheng H; Fu Q; Ma K; Shi S; Fu Y
    Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated hsa_circ_0004458 Contributes to Progression of Papillary Thyroid Carcinoma by Inhibition of miR-885-5p and Activation of RAC1.
    Jin X; Wang Z; Pang W; Zhou J; Liang Y; Yang J; Yang L; Zhang Q
    Med Sci Monit; 2018 Aug; 24():5488-5500. PubMed ID: 30086127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0010023 promotes the development of papillary thyroid carcinoma by sponging miR-1250-5p.
    Wang L; Wang Y; Wu W; Qian L; Jin P
    Endocrine; 2024 Nov; 86(2):744-752. PubMed ID: 38914746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive circular RNA profiling reveals the regulatory role of circRNA_0007694 in papillary thyroid carcinoma.
    Long MY; Chen JW; Zhu Y; Luo DY; Lin SJ; Peng XZ; Tan LP; Li HH
    Am J Transl Res; 2020; 12(4):1362-1378. PubMed ID: 32355548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
    Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
    Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3-mediated m6A Modification of hsa_circ_0131922 Attenuates the Progression of Papillary Thyroid Cancer by Regulating the p53 Pathway.
    Li C; Xie P; Lv K; Yang Q; Mou Y
    Endocr Metab Immune Disord Drug Targets; 2024 Jul; ():. PubMed ID: 39021178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray profiling of circular RNAs in human papillary thyroid carcinoma.
    Peng N; Shi L; Zhang Q; Hu Y; Wang N; Ye H
    PLoS One; 2017; 12(3):e0170287. PubMed ID: 28288173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has_circ_0008274 promotes cell proliferation and invasion involving AMPK/mTOR signaling pathway in papillary thyroid carcinoma.
    Zhou GK; Zhang GY; Yuan ZN; Pei R; Liu DM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8772-8780. PubMed ID: 30575918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile and clinical implication of circular RNAs in human papillary thyroid carcinoma.
    Ren H; Liu Z; Liu S; Zhou X; Wang H; Xu J; Wang D; Yuan G
    PeerJ; 2018; 6():e5363. PubMed ID: 30123704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.
    Shen C; Wu Z; Wang Y; Gao S; Da L; Xie L; Qie Y; Tian D; Hu H
    Cancer Med; 2020 Jun; 9(11):3885-3903. PubMed ID: 32250047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.